Tandem Diabetes Care (TNDM) Stock: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$17.15
0.80 (4.89%)
â˛
5d:
+3.81%
30d:
+4.7%
90d:
+0.18%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TNDM is fairly priced but lacks strong directional signals. At -16.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TNDM is fairly priced but lacks strong directional signals. At -16.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $17.15, which is considered fair relative to its 30-day fair value range of $15.92 to $17.00. From a valuation perspective, the stock is trading at a discount (Forward PE: 102.8) compared to its historical average (178.5). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $17.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: TNDM scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.76 (+69.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $17.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: TNDM scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.76 (+69.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.92 -
$17.00
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 69.8% below Wall St target ($27.76)
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$15.92 -
$17.00
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$15.38
Resistance Level
$17.25
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
102.83
Wall Street Target
$27.76
(+69.8%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
-37.0%
Profit Margin
-6.1%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
102.8 vs 178.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$14.72
(-10%)
2-Year Target
$13.24
(-19%)
3-Year Target
$11.92
(-27%)
3-Yr Target (if PE normalizes)
(PE: 103â179)
$20.69
(+27%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 102.8 to 178.5
Stabilization Target:
$28.38
(+73.6%)
PE Expansion Potential:
+73.6%
Share & Embed Analysis
Last updated: October 22, 2026 4:55 PM ET
Data refreshes hourly during market hours. Next update: 5:55 PM
Data refreshes hourly during market hours. Next update: 5:55 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 51 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
